Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Three tetracyclines, one shared origin, but real differences in absorption, tissue reach, and safety that matter when choosing a treatment.
Azithromycin was long the go-to single-dose chlamydia treatment, but new evidence has shifted guidance toward doxycycline. Here's what changed, why, and what remains true.
Albendazole barely dissolves in water, so the body relies on dietary fat and bile to carry it into the bloodstream. Here's the pharmacology behind that dependency.
Strongyloides stercoralis can replicate silently inside the human body for 50+ years via autoinfection. Here's the biology, the danger, and why ivermectin remains the treatment of choice.
Ivermectin's decades-long safety record rests on a specific biological gatekeeper. Here is how P-glycoprotein at the blood-brain barrier explains it.
Ivermectin's success against parasitic worms can come with a temporary flare of fever, itching and swelling. Here is the biology behind it, and why it matters.
Ivermectin traces to a Japanese soil sample and a decades-long research partnership. Here is the real science behind its discovery, its 2015 Nobel Prize, and its actual approved uses.
A tiny mite that lives on nearly every adult face may drive rosacea's flares in some patients—and a soil-derived compound helps calm it.
Azithromycin's short course isn't a shortcut — it reflects unique pharmacokinetics that let the drug keep working long after the last pill.